510(k) Report

510(k) · Cleared

Cleared

Cytori Celution Cell Concentration Device

K060482510(k) TraditionalCleared Sep 28, 2006217-day reviewClass II21 CFR 868.5830

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cytori Therapeutics, Inc. · CAC Apparatus, Autotransfusion

Cleared on Sep 28, 2006 as substantially equivalent to K972894 (Medtronic Blood Management, 1998) and 2 other predicates after a 217-day review. Its family tree reaches back 3 generations to 1989.

Decided
Sep 28, 2006
Review
217 days
Class
Class II
Product code
CAC
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K884564 (1989). 9 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1998: 3 other ancestors1999: 1 other ancestor1995: 1 other ancestor1991: 1 other ancestorK884564 · Shiley Therapeutic Autotransfusion System-Programm · Shiley, Inc. · 1989K982650 · Autologous Blood Management System (Abms) · Dideco S.P.A. · 1998 · recalledK020647 · Dideco Electa · Dideco S.P.A. · 2002 · recalled19851990199520002005
  1. Root · 3 generations backK884564 Shiley Therapeutic Autotransfusion System-ProgrammShiley, Inc. · 1989
  2. 2 generations backK982650 Autologous Blood Management System (Abms)Dideco S.P.A. · 1998 · Recalled
  3. 1 generation backK020647 Dideco ElectaDideco S.P.A. · 2002 · Recalled
  4. This deviceK060482 Cytori Celution Cell Concentration DeviceCytori Therapeutics, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K884564Shiley Therapeutic Autotransfusion System-ProgrammShiley, Inc.1989—
−2K982650Autologous Blood Management System (Abms)Dideco S.P.A.19982
−1K020647Dideco ElectaDideco S.P.A.20022
0 (this device)K060482Cytori Celution Cell Concentration DeviceCytori Therapeutics, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199510
199830
199910
FIG. 1 — Lineage of K060482, 1989–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAC device

  1. #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972894Autotransfusion Appartus (Autolog)
Summary page 4
…with the following predicate devices which have been determined by FDA to be substantially equivalent to pre-amendment devices: Medtronic Autolog Autotransfusion System (K972894), Dideco Electra (K020647), and Dideco Autologous Blood Management System (K982650). Indications For Use The Cytori Therapeutics…
Medtronic Blood Management19981
*K020647Dideco Electa
Summary page 4
…te devices which have been determined by FDA to be substantially equivalent to pre-amendment devices: Medtronic Autolog Autotransfusion System (K972894), Dideco Electra (K020647), and Dideco Autologous Blood Management System (K982650). Indications For Use The Cytori Therapeutics Celution Cell Concentrati…
Dideco S.P.A.20022
*K982650Autologous Blood Management System (Abms)
Summary page 4
…ntially equivalent to pre-amendment devices: Medtronic Autolog Autotransfusion System (K972894), Dideco Electra (K020647), and Dideco Autologous Blood Management System (K982650). Indications For Use The Cytori Therapeutics Celution Cell Concentration Device and the predicate devices share substantially e…
Dideco S.P.A.19982

Also cleared against K972894: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 3 companies; a new generation was cleared every 4.1 years on median.
  • 3 of the 9 ancestors have a recall of any class.
  • 1 other device also cites its predicate K972894.

How does its category compare?

All CAC devices

CAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAC

3in 2024

2008: 12010: 42011: 22012: 32013: 12014: 32016: 22017: 12018: 22019: 12020: 12021: 42022: 12023: 22024: 3
2007high 4 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAC

91in 2024

2010: 123 days median2012: 90 days median2014: 269 days median2021: 155 days median2024: 91 days median
2007high 269 (2014) · low 90 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAC

7in 2023

2007: 12008: 52009: 252010: 32011: 32013: 92017: 22018: 22019: 232023: 7, 2 Class I
2007high 25 (2009) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CAC

128in 2025

2007: 352008: 122009: 682010: 1152011: 9392012: 2492013: 1532014: 902015: 872016: 732017: 882018: 872019: 642020: 1082021: 732022: 652023: 392024: 1292025: 128
2007high 939 (2011) · low 12 (2008)2025

MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—135
20081—512
20090—2568
201041233115
20112—3939
20123900249
20131—9153
20143269090
20150—087
20162—073
20171—288
20182—287
20191—2364
20201—0108
20214155073
20221—065
20232—7 (2)39
20243910129
20250—0128
20260—0—

What is it indicated for?

The Cytori Celution Cell Concentration Device is indicated for the collection, concentration, washing, and reinfusion of autologous cells collected intraoperatively or postoperatively to obtain concentrated blood cells for reinfusion. Such areas of application may include, but are not limited to, the following:

• General Surgery

* Cardiovascular Surgery

* Orthopedic Surgery

* Vascular Surgery

* Plastic/Reconstructive Procedures

* Obstetric/Gynecologic Surgery

* Neurosurgical Procedures

* Thoracic Surgery

* Transplantation Surgery

* Emergency / Trauma Procedures

* Urology Procedures

Postoperative Treatment Areas

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K060482: Cytori Celution Cell Concentration Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K060482

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026